Skip to main content

Table 2 Presence of HPV and EBV DNA in control, LSIL, HSIL and cervical cancer samples

From: Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study

Control/Lesion Type HPV and EBV detection
HPV, n (%)* EBV, n (% )** HPV/EBV co-infection, n (%)*** No HPV and EBV infection, n (%)
Control (n = 15) 4 (26.6) 8 (53.3) 2 (13.3) 5 (33.3)
LSIL (n = 17) 11 (64.7) 13 (76.4) 8 (47.1) 1 (5.8)
HSIL (n = 15) 8 (53.3) 7 (46.7) 4 (26.6) 4 (26.6)
Cancer (n = 18) 14 (77.8) 11 (61.1) 10 (55.5) 3 (16.6)
Total (n = 65) 37 (56.9) 39 (60.0) 24 (36.9) 13 (20.0)
  1. * p= 0.005 (Control versus Cancer).
  2. ** p= 0.732 (Control versus Cancer).
  3. *** p= 0.027 (Control versus Cancer).
  4. LSIL, low-grade squamous intraepithelial lesions; HSIL, high-grade squamous intraepithelial lesions.